oubari pharma website

Oubari Pharma’s New Website is now Online

By | Conferences, Events | No Comments

Oubari Pharma launches its new state of the art website today hoping to provide its visitors with an improved browsing experience and richer content.

The website is now built with several new features including:

  • An improved search function with autocomplete.
  • Individual product pages that now provide more information about every product.
  • Mobile & Tablet Support.
  • Retina Screen Compatibility.
  • Social Media Support.

We hope that the new features give you a pleasurable browsing experience and that you find our website useful.

vietnam medi-pharm

Oubari Pharma Participates in MEDI-PHARM 2011 in Vietnam

By | Conferences, Events | No Comments

MEDIPHARM is an annual exhibition featuring products, equipment, and supplies for the pharmaceutical and health industries. The exhibition was held between May 11 and the 14th, 2011 at the Friendship Cultural Palace in Hanoi. Oubari Pharma’s stand featured its wide product range and attracted some of the major importers & distributors for pharmaceutical products in the region.

Oubari Pharma Launches Neomeril Across Syria

By | Conferences, Product News | No Comments

Oubari Pharma held seminars in Aleppo, Damascus, Hama, and Homs where the company introduced NEOMERIL, a product used to effectively reduce the risk of cardiovascular events in patients with stable ischaemic heart disease.

The first seminar was held at the Sheraton Hotel in Aleppo on the 26th of January, 2011, whereas the second took place on February the 23rd at the Sheraton Hotel in Damascus. The third and fourth seminars both took place in Hama and Homs on the 24th of March at the Afamia Al-Cham Hotel and the Safire Hotel, respectively.

The seminars were attended by a large number of the country’s leading doctors, mainly whom were specialized in the treatment of cardiac, internal, and renal diseases. Each seminar featured a thorough presentation of NEOMERIL by Dr. Safwan Al-Kadi*, a highly recognized cardiologist and lecturer. In his presentations, Dr. Al-Kadi explained the mechanism of atherosclerosis and declared that smoking, obesity, hypertension, hypercholesterolemia, hyperlipidemia, and stress are risk factors that may provoke an inflammatory reaction in Intima (the innermost coat of blood vessels). Those risk factors may also lead to the self-destruction of vessel cells, a phenomenon known as Apoptosis (programmed cell death), resulting in artery stenosis and clot formation. Dr. Al-Kadi later described the role of NEOMERIL in preventing the occurrence of Apoptosis as well as preventing inflammatory phenomena in the arteries wall. Finally, he concluded by declaring that NEOMERIL (perindopril erbumine) must be considered as one of the basic medicaments in treating stable coronary artery disease.

Dr. Amer Kasrawi, medical advisor at Oubari Pharma, explained that the seminars were aimed at keeping doctors up to date with Oubari Pharma’s latest products as well as discussing new developments in the treatment of cardiovascular diseases and atherosclerosis, mainly stable coronary artery diseases. On the other hand, he considered all seminars successful, and on behalf of Oubari Pharma thanked all participants for attending.


*Dr. Safwan Al-Kadi is a graduate of Rene Descartes Paris, holds a D.U. certificate in Echocardiography from Pierre & Marie Curie, and a D.U. certificate in Sonography from Pitie Salpetriere in France.

Oubari Pharma Participates in Arab Health 2011

By | Conferences, Events | No Comments

Following the success of its first participation at Arab Health in 2006, Oubari Pharma re-visited Dubai to take part in this year’s event, held between January the 24th and the 27th, 2011. The Company’s stand attracted a large number of healthcare professionals and organizations from both the Arab world and beyond. The exhibition was an excellent platform to meet both potential partners and our current international clients. The Company has rapidly been expanding its export initiatives, entering new markets and increasing its activities in others. Oubari Pharma’s extensive range of products has steadily managed to earn the trust of both physicians and patients across the region. Featuring over 2,700 exhibitors from 60 countries, The Arab Health Exhibition & Congress is the largest healthcare exhibition in the Middle East, and the second largest in the world.